You are here: Industry Insights > COVID-19

News List

SII enrols 6000 subjects for efficacy trial of rBCG vaccine, VPM1002 against COVID-19 expresspharma
July 28, 2020
The DBT-BIRAC supported trial aims to evaluate the ability of VPM1002 in reducing infection incidence and severe disease outcomes of COVID-19 among high-risk persons of advanced age or co-morbidities and high-exposure healthcare workers.
People at high risk of diabetes fast-tracked into prevention programme pharmatimes
July 27, 2020
People at high risk of developing type II diabetes will be fast-tracked into the Healthier You NHS Diabetes Prevention programme, on the back of research indicating that people with the condition are at significantly higher risk of dying with COVID-19.
FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing americanpharmaceuticalreview
July 27, 2020
The U.S. Food and Drug Administration (FDA) reissued an emergency use authorization (EUA) to Quest Diagnostics to authorize its Quest SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to four individual swab specimens collected under ...
Luminex Receives EUA for COVID-19 Antibody Test americanpharmaceuticalreview
July 27, 2020
Luminex announced the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's xMAP? SARS-CoV-2 Multi-Antigen IgG Assay.
Heron Begins Phase 2 Clinical Study of Cinvanti for COVID-19 americanpharmaceuticalreview
July 27, 2020
Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating CINVANTI (aprepitant) injectable emulsion in early hospitalized patients with Coronavirus Disease 2019 (COVID-19).
US DoJ calls for increased Covid-19 monoclonal antibody production pharmaceutical-technology
July 27, 2020
The US Department of Justice (DoJ) has said that it will not challenge efforts by drugmakers to share information to scale up the manufacturing of monoclonal antibody treatments for Covid-19.
Novavax, FUJIFILM Initiate Large Scale Mfg. of COVID-19 Vax Candidate contractpharma
July 27, 2020
FUJIFILM to manufacture bulk drug substance for NVX-CoV2373 from its site in Morrisville, NC for Phase III trial.
Animal replacement method for vaccine testing developed by Intravacc and Leiden University expresspharma
July 27, 2020
As a result of the Covid-19 pandemic, some 400 therapies and vaccines against this virus are currently being developed worldwide. This affects the number of laboratory animals used in studies.
Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19 expresspharma
July 27, 2020
Favipiravir is a broad spectrum anti-viral agent and selectively inhibits RNA polymerase of influenza virus and prevents viral replication.
COVID-19 has pushed infectious disease drugs to be top CSAs: GlobalData expresspharma
July 27, 2020
COVID-19 may also be disrupting other therapy areas by reducing service agreements for other non-COVID-19 drugs.